[go: up one dir, main page]

WO2018168525A1 - Levure riche en polyamine et composition d'aliment/boisson en contenant - Google Patents

Levure riche en polyamine et composition d'aliment/boisson en contenant Download PDF

Info

Publication number
WO2018168525A1
WO2018168525A1 PCT/JP2018/008043 JP2018008043W WO2018168525A1 WO 2018168525 A1 WO2018168525 A1 WO 2018168525A1 JP 2018008043 W JP2018008043 W JP 2018008043W WO 2018168525 A1 WO2018168525 A1 WO 2018168525A1
Authority
WO
WIPO (PCT)
Prior art keywords
yeast
chromosome
gene
polyamine
encoded
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2018/008043
Other languages
English (en)
Japanese (ja)
Inventor
優典 玉腰
武士 新堀
智子 伊丸岡
池本　一人
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Gas Chemical Co Inc
Original Assignee
Mitsubishi Gas Chemical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Gas Chemical Co Inc filed Critical Mitsubishi Gas Chemical Co Inc
Priority to KR1020197027111A priority Critical patent/KR102127479B1/ko
Priority to JP2019505879A priority patent/JP6663598B2/ja
Publication of WO2018168525A1 publication Critical patent/WO2018168525A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/14—Yeasts or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/001—Amines; Imines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds

Definitions

  • the present invention relates to a polyamine-rich yeast, particularly a spermidine-rich yeast and a food or beverage composition containing the same.
  • polyamines In the functional food field, those capable of activating cells are required. Among them, linear in-vivo aliphatic hydrocarbons having two or more primary amino groups called polyamines have a high effect, and their contents are provided as foods.
  • Representative polyamines include putrescine, spermidine and spermine.
  • Physiological actions of polyamines include (1) cell proliferation action, (2) cell differentiation promoting action, (3) immune essential factor, (4) antiallergic action, (5) protein synthesis promoting action, (6) nucleic acid Structure stabilization by interaction, (7) enzyme activity regulating action and the like are known. Recently, it has been reported that polyamines taken orally prolong life.
  • Patent Document 1 As a production method of a polyamine or a polyamine composition that can be used industrially, a method of preparing yeast cells or a yeast culture solution by treatment under acidic conditions (Patent Document 1) is disclosed.
  • Patent Document 2 a method of extracting the plant material under acidic conditions (Patent Document 2), adding a salt solution such as salt, magnesium chloride, calcium chloride to the plant material.
  • Patent Document 3 A method for producing a polyamine extract (Patent Document 3) has been studied. In fact, rice extract, soybean extract, and yeast extract exist as foods containing a high amount of polyamine. These polyamine-rich foods have been found to activate cells, but there is a need for foods that further activate cells.
  • Patent Document 4 a method of obtaining yeast having a high polyamine content by mixing a reagent polyamine with a yeast culture solution (Patent Document 4) is also known, but it is recognized as a food rather than causing the yeast itself to produce polyamine.
  • Patent Document 4 there is a problem that it is not permitted to provide such a yeast as a food because a method of introducing a pure product of polyamine not introduced from the outside is employed.
  • spermidine and spermine have a high utilization rate in the body and are excellent in terms of functionality.
  • spermidine has an allowable daily intake higher than that of spermine and is preferable for taking a larger amount (Non-patent Document 2).
  • An object of the present invention is to provide a polyamine-rich yeast that activates cells more, particularly a yeast containing a high amount of spermidine, and a food or drink composition containing the same.
  • the present invention includes the following inventions.
  • [1] In comparison with Association No. 7 yeast, One or several amino acid substitutions or deletions in one or more amino acid sequences of leucine synthase, aconitate synthase, S-adenosyl-L-methionine synthase, aspartate / glutamate transfer protein Mutated by insertion or addition, or a combination of two or more thereof, or the LEU1 gene encoded by chromosome 3, the ACO2 gene encoded by chromosome 10, and encoded by chromosome 12 In one or more base acid sequences of the SAM1 gene, the AGC1 gene encoded by chromosome 16, one or several bases are substituted, deleted, inserted or added, or two or more thereof Has been mutated in combination, A yeast mutant containing a high amount of polyamine.
  • the base corresponding to the 266th C of the LEU1 gene is A
  • the base corresponding to the 1964th T of the ACO2 gene encoded in the 10th chromosome is C
  • the 1130th of the SAM1 gene encoded in the 12th chromosome The yeast mutant according to [2], wherein the base corresponding to C is G, and the base corresponding to the 744th A of the AGC1 gene encoded by chromosome 16 is T.
  • a food and beverage composition comprising the yeast variant according to any one of [1] to [5] and a crystalline polysaccharide.
  • [7] [6] The composition according to [6], wherein the weight ratio of the yeast variant to the crystalline polysaccharide is 1: 0.1 to 1.
  • [8] The composition according to [6] or [7], wherein the crystalline polysaccharide is cyclodextrin and / or indigestible dextrin. [9] In comparison with Association No.
  • yeast One or several amino acid substitutions or deletions in one or more amino acid sequences of leucine synthase, aconitate synthase, S-adenosyl-L-methionine synthase, aspartate / glutamate transfer protein Mutated for insertion or addition, or combinations of two or more thereof, or LEU1 gene encoded by chromosome 3, ACO2 gene encoded by chromosome 10, SAM1 encoded by chromosome 12 Any one or more base acid sequences of the gene, the AGC1 gene encoded on chromosome 16, wherein one or several bases are substituted, deleted, inserted or added, or two or more thereof Mutating in combination, A method for producing a yeast mutant containing a high amount of polyamine.
  • the genome of the obtained mutant strain was analyzed using Illumina HiSeq and compared with the sequence of the wild strain. As a result, homozygous mutations in four genes involved in polyamine synthesis were confirmed.
  • the 266th C of the leucine synthesis gene LEU1 encoded by the third chromosome is encoded by A
  • the 1964th T of the aconitic acid synthesis gene ACO2 encoded by the 10th chromosome is encoded by C
  • the twelfth chromosome is encoded by
  • the 1130th C of the S-adenosyl-L-methionine synthesis gene SAM1 was mutated to G
  • the 744th A of the aspartate / glutamate transport gene AGC1 encoded on chromosome 16 was mutated to T.
  • the present invention it is possible to provide a yeast having a high polyamine content, particularly a yeast having a high content of spermidine, and a food or drink containing the same, which is effective for cell activation.
  • the yeast which concerns on this invention can exhibit the effect of cell activation from the conventional rice extract, soybean extract, and yeast extract of the same polyamine content by containing a polyamine in yeast.
  • the polyamine-rich yeast obtained in the present invention is excellent in the thermal stability of polyamines including spermidine when combined with crystalline polysaccharides. Therefore, by combining the yeast of the present invention with a crystalline polysaccharide, it becomes possible to provide a polyamine-rich food / beverage product that can be easily cooked.
  • FIG. 1 shows the base sequence of the LEU1 gene of the yeast according to the present invention in comparison with the wild type (Association No. 7 yeast).
  • FIG. 2-1 shows the base sequence of the ACO2 gene of the yeast according to the present invention in comparison with the wild type (Association No. 7 yeast).
  • FIG. 2-2 shows the base sequence of the ACO2 gene of the yeast according to the present invention in comparison with the wild type (Association No. 7 yeast).
  • FIG. 3 shows the base sequence of the SAM1 gene of the yeast according to the present invention in comparison with the wild type (Association No. 7 yeast).
  • FIG. 4-1 shows the base sequence of the AGC1 gene of the yeast according to the present invention in comparison with the wild type (Association No. 7 yeast).
  • FIG. 4-2 shows the base sequence of the AGC1 gene of the yeast according to the present invention in comparison with the wild type (Association No. 7 yeast).
  • the invention relates to one or more of leucine synthase, aconitate synthase, S-adenosyl-L-methionine synthase, aspartate / glutamate transporter protein as compared to Association 7 yeast. Or less, preferably 20 or less, more preferably 1 or several, such as 2, 3, 4, 5, 6, 7, 8, 9, or 10.
  • One or more basic acids of the SAM1 gene encoded by chromosome 12 and the AGC1 gene encoded by chromosome 16 In the sequence one or several, eg 2, 3, 4, 5, 6, 7, 8, 9, 9 or 10 bases are substituted, deleted, inserted or added, or they Mutated in a combination of two or more of
  • a yeast mutant containing a high amount of polyamine hereinafter also referred to as “mutant yeast”, “mutant”, or “polyamine-rich yeast”
  • the yeast variant according to the present invention contains 1.5 mg or more, preferably 2.0 mg or more, more preferably 3.0 mg, and still more preferably 10 mg or more of polyamine per 1 g (dry weight) of yeast. obtain.
  • Mutant yeast can be obtained by mutating yeast belonging to the genus Saccharomyces, preferably Saccharomyces cerevisiae, by methods known to those skilled in the art. More specifically, the variant of the present invention can be obtained by irradiating ultraviolet rays to No. 7 strain of the Japan Brewing Association (hereinafter also referred to simply as “No. 7 strain”). The mutant of the present invention can be obtained by irradiating Saccharomyces cerevisiae IFO2346 described in Japanese Patent No. 5974891 with ultraviolet rays.
  • a yeast containing a high amount of polyamine another strain having a high ability to synthesize and accumulate polyamine may be used. It is possible to increase the concentration of polyamine contained in the cells by culturing yeast in a medium containing a large amount of polyamine, or by applying stress (osmotic pressure due to addition of ethanol, salt, etc.).
  • the body differs from normal yeast in that it has a function of producing a large amount of polyamine and accumulating it in the microbial cells without undergoing such operations.
  • osmotic stress with ethanol, salt, etc.
  • productivity is extremely low.
  • a polyamine-rich yeast such as a spermidine-rich yeast can be obtained even in non-stress culture, the productivity is excellent.
  • the yeast having a high polyamine content of the present invention is obtained by cultivating yeast as a starting material such as Association No. 7 strain in a medium containing a yeast extract, collecting the cells after culturing, heat sterilizing, and subjecting them to spray drying. can get.
  • the polyamine-rich yeast of the present invention can be obtained by culturing yeast strains mutated by a method known to those skilled in the art, such as ultraviolet irradiation, in a medium containing a yeast extract, collecting the cells after culturing, and spraying them after heat sterilization. Obtained by drying.
  • the concentration of yeast extract in the medium is preferably 0.1% or more and 10% or less.
  • the mutation treatment method is not particularly limited, and a known method can be used.
  • methods such as chemical treatment with ethyl methanesulfonic acid, N-methyl-N-nitro-N-nitrosoguanidine, nitrous acid, acridine dye, ultraviolet irradiation;
  • Mutation site is mutated so that at least one amino acid sequence or base sequence of leucine synthase, aconitate synthase, S-adenosyl-L-methionine synthase, aspartate / glutamate transport protein contains high polyamine As long as it is, it is not particularly limited. More specifically, in comparison with the gene sequence of Association No. 7 yeast, the 266th C of the LEU1 gene encoded by the third chromosome is A, and the 1964th of the ACO2 gene encoded by the 10th chromosome. It is preferable that C in the SAM1 gene encoded by chromosome 12 is replaced by G and T in 744 of the AGC1 gene encoded by chromosome 16 is replaced by T. . Such point mutation can be introduced by a known genetic engineering technique or the like.
  • point mutation refers to a single base substitution found on the corresponding base sequence in the present invention by comparison with the base sequence of Association No. 7 strain.
  • Point mutations usually include transition mutations that are substitutions between purines or pyrimidines, or transversion mutations that are substitutions between purines and pyrimidines. In the present invention, however, mutant yeasts are high in polyamine content. Any mutation may be used.
  • Point mutations are known biological techniques, such as PCR using primers designed to introduce the desired mutation, or donors that are homologous to the locus on either side (for example, a single-stranded oligo) It can be introduced according to a genome editing technique (CRISPR / Cas9) using nucleotides or plasmids).
  • CRISPR / Cas9 genome editing technique
  • Polyamine is a general term for linear aliphatic hydrocarbons in which a plurality of amino groups are bonded. Examples thereof include putrescine, spermidine, spermine, 1,3-diaminopropane, cadaverine, cardine, homospermidine, aminopropyl cadaverine, theremin, Examples include thermospermine, canabalmin, aminopentylnorspermidine, N, N-bis (aminopropyl) cadaverine, homospermine, cardopentamine, homocardopentamine, cardohexamine, and homocardohexamine spermidine. Unless otherwise specified, “polyamine” as used herein means one or more compounds selected from the group consisting of putrescine, spermidine and spermine, which have a high cell activation ability.
  • the amount of polyamine can be measured by adding the amounts of putrescine, spermidine and spermine extracted from spray-dried yeast.
  • Dry yeast is obtained by removing cells from a yeast-containing medium by filtration or a centrifuge and drying the cells. Washing may be performed to remove the medium components.
  • spray drying, reduced-pressure drying, freeze-drying, etc. can be used for drying of yeast, and those skilled in the art can select a drying method suitably according to the objective.
  • composition containing polyamine-rich yeast provides a composition comprising a polyamine-rich yeast, in particular a spermidine-rich yeast, in particular a cell activating composition.
  • the composition may contain a crystalline polysaccharide in addition to the yeast.
  • Crystalline polysaccharide means a polysaccharide that exists as a natural, crystalline solid, examples of which include starch, dextrin, glycogen and cellulose.
  • Cyclodextrin which is a dextrin having a cyclic structure, can be suitably used as a crystalline polysaccharide.
  • Cyclodextrins include alpha, beta, and gamma types, all of which can be used as crystalline polysaccharides. Among these, alpha-cyclodextrin and gamma-cyclodextrin are preferable.
  • Other dextrins such as indigestible dextrins, can also be used in the compositions of the present invention.
  • the weight ratio of the polyamine-rich dry yeast and the crystalline polysaccharide is preferably 1: 0.1-3. More preferably, the weight ratio of polyamine-rich yeast to crystalline polysaccharide is 1: 0.1 to 1. If the crystalline polysaccharide is less than this, the stability of the yeast is lowered. In addition, if it is higher than this range, the content of polyamine, especially spermidine per composition, becomes too low, and it is necessary to ingest a large amount of the composition in order to exert a desired function such as spermidine in the human body. There is.
  • yeast By combining yeast with a high polyamine content and a crystalline polysaccharide, the yeast can be made stable and easy to handle.
  • Mixing of yeast and crystalline polysaccharide may be either dry or wet. In the case of wet treatment, the sugar can be sterilized, mixed with yeast and dried. Moreover, it is possible to make a composition by mixing as undried yeast and then drying without mixing as dry yeast.
  • a composition containing a crystalline polysaccharide can be obtained by, for example, cultivating yeast for 4 days, collecting and concentrating by centrifugation, and adding ⁇ -cyclodextrin thereto. Obtained by heating at 60 ° C. for 1 hour and spray drying it.
  • composition of the present invention is assumed to be used for various purposes.
  • the composition of the present invention is not only a variety of general foods and drinks, but also foods and drinks whose functionality is displayed so that individuals who need nutritional enhancement, especially individuals who need cell activity, can be ingested.
  • specific health foods and beverages, nutritional functional foods and beverages, functional skin foods and beverages, health functional foods and beverages, special purpose foods and beverages, nutritional supplements and foods, health supplemental foods and beverages, supplements, beauty foods and beverages, and other health products It can be included in food and drink, medicines, quasi drugs, and cosmetics.
  • the mutant yeast as an active ingredient may be contained in the composition as it is, or may be added to the composition after being crushed and powdered. Additives such as other physiologically active ingredients and excipients can also be added to the composition.
  • the form of the composition is not particularly limited, and can be in the form of powder, granule, tablet, capsule, jelly or the like. A specific form may be further processed. For example, the surface of a tablet-like composition obtained by compression tableting may be coated. Also, the powder can be granulated, or the powder or granulated granule can be packed and encapsulated.
  • the composition of the present invention can be used as a food in the form of a tablet or powder. Moreover, it can be added to nutritional supplements such as foods and beverages such as juices and dairy products and supplements for the purpose of enhancing nutrition.
  • the form may be a common form such as liquid, tablet, powder, capsule and the like.
  • the composition of this invention is not food-drinks itself, it can also be used as a seasoning added to food-drinks.
  • the composition desirably contains 50 to 100% of yeast.
  • the present invention provides a method for producing a polyamine-rich yeast.
  • the method for producing polyamine-rich yeast is compared with Association 7 yeast.
  • One or several amino acid substitutions or deletions in one or more amino acid sequences of leucine synthase, aconitate synthase, S-adenosyl-L-methionine synthase, aspartate / glutamate transfer protein Mutated for insertion or addition, or combinations of two or more thereof, or LEU1 gene encoded by chromosome 3, ACO2 gene encoded by chromosome 10, SAM1 encoded by chromosome 12 Any one or more base acid sequences of the gene, the AGC1 gene encoded on chromosome 16, wherein one or several bases are substituted, deleted, inserted or added, or two or more thereof Mutating in combination.
  • the method may further include an optional step of causing the yeast to have a high polyamine content.
  • the mixture was further mixed with 0.5 ml of 1% dansyl chloride and held at 45 ° C. for 1 hour. To this, 0.25 ml of 10% proline aqueous solution was added, and further maintained at 45 ° C. for 10 minutes. Thereafter, 2 ml of toluene was added to the mixture, and after vigorous mixing, 1 ml of a toluene layer was obtained. Further, the toluene layer was dried by blowing nitrogen, and redissolved in 0.5 ml of acetonitrile was analyzed by liquid chromatography.
  • the calibration curve was prepared by fixing a concentration of 1,7-diaminoheptane to 2 ppm, and preparing a dilution series of 0.125 to 8 ppm for each polyamine of spermidine, spermine, and putrescine, and analyzing the liquid chromatography (peak area). Value). Unless otherwise specified, the above-mentioned reagents were manufactured by Wako Pure Chemical.
  • Saccharomyces (Association No. 7 strain) was used as the yeast.
  • the parent strain was cultured with shaking in a liquid medium containing 1% Bacto yeast extract, 2% Bacto peptone, and 2% glucose at 30 ° C. for 16 hours, and the culture solution was irradiated with 45 W ultraviolet light. Thereafter, the culture solution was diluted 1 to 100,000 times with 50 mM potassium phosphate buffer (pH 7), and applied to an agar medium containing 1% Bacto yeast extract, 2% Bacto peptone, 2% glucose, and 2% agarose. The agar medium was allowed to stand at 30 ° C. for 2 days, and a polyamine-producing strain was determined from the colonies that appeared.
  • GenTLE-kun registered trademark
  • Takara Bio Inc. Japan Bio Inc.
  • the genome analysis of the high-producing strain was performed using Illumina HiSeq, and compared with the sequence of the wild strain, homozygous mutations in four genes involved in the synthesis of polyamine were confirmed.
  • the 266th C of the leucine synthesis gene LEU1 encoded by the third chromosome is A
  • the 1964th T of the aconitic acid synthesis gene ACO2 encoded by the 10th chromosome is encoded by C
  • the 1130th C of the S-adenosyl-L-methionine synthesis gene SAM1 is mutated to G
  • the 744th A of the aspartate / glutamate transporter gene AGC1 encoded by chromosome 16 is mutated to T I understood.
  • the nucleotide sequences according to the present invention are shown in SEQ ID NOs: The type is shown in SEQ ID NO: 2, 4, 6, 8.
  • Example 1 The mutant yeast strain with high polyamine production was cultured. Culture is sucrose 50 g / L, ammonium sulfate 3 g / L, potassium dihydrogen phosphate 4 g / L, dipotassium hydrogen phosphate 2 g / L, magnesium sulfate heptahydrate 0.4 g / L, bacto yeast extract 10 g / L, Biotin 0.002g / L, calcium chloride dihydrate 0.4g / L, manganese chloride tetrahydrate 0.01g / L, zinc sulfate heptahydrate 0.02g / L, iron citrate n hydrate 0.06 g / L, boric acid 0.002 g / L, ammonium molybdate tetrahydrate 0.001 g / L, potassium iodide 0.001 g / L, copper sulfate pentahydrate 0.
  • the test was carried out in a medium having a composition of 001 g / L, cobalt chloride hexahydrate 0.001 g / L, and sodium chloride 0.05 g / L.
  • the mutant yeast was cultured for 4 days with stirring at a culture temperature of 30 ° C.
  • the culture broth was centrifuged to concentrate the cells and further washed with water. This was heat-treated at 60 ° C. for 1 hour and spray-dried.
  • a Büch mini spray dryer b-290 was used for spray drying. Dry yeast was obtained at an outlet temperature of 85-90 ° C.
  • the dry yeast contained putrescine 0.72 mg / g, spermidine 3.62 mg / g, spermine 0.38 mg / g (total 4.72 mg / g).
  • S-adenosylmethionine (SAMe) -containing yeast was obtained by the method described in paragraph No. 0014 of Japanese Patent No. 5974891. Putrescine was not detected, spermidine was 0.29 mg / g, spermine was 0.16 mg / g (total 0.45 mg / g).
  • Example 2 In order to confirm the effect of the crystalline polysaccharide, in addition to the above-mentioned Examples and Comparative Examples, a sample to which ⁇ -cyclodextrin was added before the spray drying step was prepared.
  • the culture solution of mutant yeast obtained in Example 1 (putrescine 0.72 mg / g, spermidine 3.62 mg / g, spermine 0.38 mg / g, total 4.72 mg / g) was centrifuged to obtain the cells. Concentrated and further washed with water. The microbial cells and ⁇ -cyclodextrin were mixed in the medium so that the ratio of the amount of microbial cells in the culture broth (bacterial concentration x broth liquid amount): cyclodextrin weight was 7: 3. The resulting mixture was treated at 60 ° C. for 1 hour.
  • the polyamine content was 0.55 mg / g putrescine, 2.63 mg / g spermidine, and 0.29 mg / g spermine per dry solid, for a total of 3.47 mg / g.
  • the yeast was spray-dried using a Büch mini spray dryer b-290. Dry yeast was obtained at an outlet temperature of 85-90 ° C.
  • This dry yeast is a powdery composition containing 30% by weight of cyclodextrin in addition to dry yeast (hereinafter, dry yeast or its powdery composition is also referred to as yeast powder).
  • the polyamine content was 0.55 mg / g for putrescine, 2.63 mg / g for spermidine, and 0.29 mg / g spermine (total 3.47 mg / g). The polyamine content did not decrease before and after spray drying.
  • Example 3 The mutant yeast of Example 1 was cultured under the same conditions as in Example 1.
  • the culture solution containing the produced yeast (putrescine 1.07 mg / g, spermidine 4.24 mg / g, spermine 0.36 mg / g, total 5.66 mg / g) is centrifuged to concentrate the cells, and further washed with water. did.
  • An aqueous solution containing ⁇ -cyclodextrin was added to the cells so that ⁇ -cyclodextrin was 50% by weight. This was treated at 60 ° C. for 1 hour.
  • the polyamine content was 0.58 mg / g for putrescine, 2.18 mg / g for spermidine, and 0.18 mg / g for spermine per dry solid content, for a total of 2.93 mg / g.
  • the yeast was spray-dried.
  • a Büch mini spray dryer b-290 was used for spray drying. Dry yeast powder was obtained at an outlet temperature of 95-100 ° C.
  • the polyamine content in the dried powder was putrescine 0.63 mg / g, spermidine 2.26 mg / g, and spermine 0.19 mg / g (total 3.08 mg / g).
  • the polyamine content did not decrease before and after spray drying.
  • Example 4 The yeast culture solution of Example 2 before the bacterial cell concentration and the yeast culture solution of Comparative Example 1 were mixed at a ratio of 2: 3, and this was treated at 60 ° C. for 1 hour. Then, dry yeast was obtained by vacuum-drying a yeast culture solution. As a result, a yeast powder having a putrescine content of 0.29 mg / g, a spermidine content of 1.75 mg / g, and a spermine content of 0.42 mg / g (total 2.46 mg / g) was obtained. It was.
  • yeast powder described in Example 1 yeast powder described in Example 2, yeast powder described in Example 4, yeast powder described in Reference Example, yeast powder described in Comparative Example 1, soybean extract (Comparative Example 2), rice germ extract (Comparative Example 3), and yeast extract (Comparative Example 4) were each suspended in water at a concentration of 10,000 mg / L and sterilized by autoclave. Each liquid was well suspended and 6.3 ul was added to the wells. By this operation, the concentration of each sample was 600 mg / L. Further, 6.3 ul of sterilized water in another well was used as a control.
  • the 96-well plate was allowed to stand at 37 ° C. and 5% carbon dioxide for 20 hours. Thereafter, the medium was discarded, and each well was washed with 100 ul of DMEM medium. Thereafter, 100 ul of a solution obtained by mixing DMEM and a cell counting kit 8 solution manufactured by Dojindo Laboratories at a volume ratio of 10: 1 was newly added to each well and allowed to stand at 37 ° C. for 40 minutes. Finally, the absorbance at 450 nm of each well was measured using Perkin Elmer ARVO X3. Cell proliferation was assessed by the ratio of absorbance to control.
  • the yeast containing a high amount of spermidine obtained in the present invention had a particularly high cell growth activity as compared with Comparative Examples 2 to 4, and was 1.6 to 1.7 times that of the control. It is thought that the cell activity ability was increased by the presence of polyamine in yeast. Polyamines have been considered to work in vivo in any form, but surprisingly, the magnitude of the effect varies depending on the form of food provided, especially in the form of polyamine-rich yeast. It was shown that it would be desirable to provide
  • the upper number is the polyamine content [mg / g], and the lower number is the ratio [%] to that before heating.
  • the upper number is the spermidine content [mg / g], and the lower number is the ratio [%] to that before heating.
  • the composition of the present invention (yeast containing high spermidine) was found to be less susceptible to polyamine reduction even after heating at 150 ° C. than conventional polyamine-containing foods. Similarly, it was shown that the amount of spermidine alone is difficult to reduce. According to the present invention, it is considered that the polyamine was stabilized by being contained in the yeast.
  • the composition (yeast containing high spermidine) of the present invention is a polyamine food which is difficult to decompose even when heated at around 150 ° C. and is easy to cook. Moreover, what added cyclodextrin was excellent in thermal stability compared with the case of no addition. It is thought that polyamines in yeast were stabilized by cyclodextrin.
  • the ⁇ over cyclodextrin yeast weight ratio of ⁇ over cyclodextrin was mixed 1: as a powder was added to a 1 (Example 5).
  • the resulting food is 50% ⁇ -cyclodextrin-containing yeast.
  • Yeast odor could be improved by using the mutant yeast of the present invention in combination with cyclodextrin.
  • Cyclodextrins can increase the stability of polyamines, increase thermal stability, and improve yeast odor as well as the effect of facilitating processing and cooking.
  • mutant yeast of the present invention contains a large amount of polyamine, particularly spermidine, in comparison with conventional yeast, it is intended to be suitably blended into foods and drinks intended for cell activation by spermidine.
  • the mutant yeast of the present invention has an effect that not only the thermal stability is increased but also the odor is reduced when used in combination with the crystalline polysaccharide.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Botany (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La présente invention concerne un mutant de levure riche en polyamine qui est muté par rapport à la levure Kyokai n°7 pour saké, car, dans la séquence d'acides aminés de l'une quelconque parmi la leucine synthase, l'acide aconitique synthase, la S-adénosyl-L-méthionine synthase et une protéine de transport d'acide aspartique/acide glutamique ou dans les séquences d'acides aminés de plus d'une desdites protéines, un ou plusieurs acides aminés sont remplacés, supprimés, insérés ou ajoutés ou au moins deux de ces mutations sont combinées ; et, en variante, dans la séquence de bases de l'un quelconque des gènes LEU 1 codé dans le chromosome 3, ACO2 codé dans le chromosome 10, SAM1 codé dans le chromosome 12 et AGC1 codé dans le chromosome 16 ou dans les séquences de bases de plus d'un desdits gènes, une ou plusieurs bases sont remplacées, supprimées, insérées ou ajoutées ou au moins deux de ces mutations sont combinées.
PCT/JP2018/008043 2017-03-17 2018-03-02 Levure riche en polyamine et composition d'aliment/boisson en contenant Ceased WO2018168525A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020197027111A KR102127479B1 (ko) 2017-03-17 2018-03-02 폴리아민 고함유 효모 및 이를 포함하는 음식품 조성물
JP2019505879A JP6663598B2 (ja) 2017-03-17 2018-03-02 ポリアミン高含有酵母及びそれを含む飲食品組成物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017-053205 2017-03-17
JP2017053205 2017-03-17

Publications (1)

Publication Number Publication Date
WO2018168525A1 true WO2018168525A1 (fr) 2018-09-20

Family

ID=63522313

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2018/008043 Ceased WO2018168525A1 (fr) 2017-03-17 2018-03-02 Levure riche en polyamine et composition d'aliment/boisson en contenant

Country Status (3)

Country Link
JP (1) JP6663598B2 (fr)
KR (1) KR102127479B1 (fr)
WO (1) WO2018168525A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021200214A1 (fr) 2020-04-03 2021-10-07 三菱瓦斯化学株式会社 Agent réduisant la graisse corporelle
WO2021200216A1 (fr) 2020-04-03 2021-10-07 三菱瓦斯化学株式会社 Agent de renforcement musculaire

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1052291A (ja) * 1996-08-12 1998-02-24 Snow Brand Milk Prod Co Ltd ポリアミンの調製方法
JP2014084302A (ja) * 2012-10-24 2014-05-12 Mitsubishi Gas Chemical Co Inc Ｓ−アデノシルメチオニン含有酵母とピロロキノリンキノン組成物
WO2015137357A1 (fr) * 2014-03-10 2015-09-17 サラヤ株式会社 Composition contenant un sophorolipide, substance, huile et matière grasse physiologiquement active, et procédé de production de cette composition
JP2017158521A (ja) * 2016-03-11 2017-09-14 日清ファルマ株式会社 ポリアミン高含有酵母及びその製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10101624A (ja) 1996-10-01 1998-04-21 Juzo Udaka ポリアミンの製造法
JP5620650B2 (ja) 2009-05-13 2014-11-05 株式会社ロッテ ポリアミンを含有する飲食品の製造方法
JP6624985B2 (ja) 2015-03-27 2019-12-25 日清ファルマ株式会社 ポリアミン高含有酵母

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1052291A (ja) * 1996-08-12 1998-02-24 Snow Brand Milk Prod Co Ltd ポリアミンの調製方法
JP2014084302A (ja) * 2012-10-24 2014-05-12 Mitsubishi Gas Chemical Co Inc Ｓ−アデノシルメチオニン含有酵母とピロロキノリンキノン組成物
WO2015137357A1 (fr) * 2014-03-10 2015-09-17 サラヤ株式会社 Composition contenant un sophorolipide, substance, huile et matière grasse physiologiquement active, et procédé de production de cette composition
JP2017158521A (ja) * 2016-03-11 2017-09-14 日清ファルマ株式会社 ポリアミン高含有酵母及びその製造方法

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CAVERO S. ET AL.: "Identification and metabolic role of the mitochondrial aspartate-glutamate transporter in Saccharomyces cerevisiae", MOLECULAR MICROBIOLOGY, vol. 50, no. 4, 7 November 2003 (2003-11-07), pages 1257 - 1269, XP055556078, Retrieved from the Internet <URL:https://doi.org/10.1046/j.1365-2958.2003.03742.x> *
CHEREST H. ET AL.: "S-Adenosyl Methionine Requiring Mutants in Saccharomyces cerevisiae: Evidences for the Existence of Two Methionine Adenosyl Transferases", MOLEC. GEN. GENET., vol. 163, no. 2, August 1978 (1978-08-01), pages 153 - 167, Retrieved from the Internet <URL:DOI:10.1007/BF00267406> *
HINNEN A. ET AL.: "Transformation of yeast", PROC. NATL. ACAD. SCI. USA, vol. 75, no. 4, 1 April 1978 (1978-04-01), pages 1929 - 1933, XP002336016, Retrieved from the Internet <URL:https://doi.org/10.1073/pnas.75.4.1929> *
PRZYBYLA-ZAWISLAK B. ET AL.: "Genetic and Biochemical Interactions Involving Tricarboxylic Acid Cycle(TCA) Function Using a Collection of Mutants Defective in All TCA Cycle Genes", GENETICS, vol. 152, no. 1, May 1999 (1999-05-01), pages 153 - 166, XP055556070 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021200214A1 (fr) 2020-04-03 2021-10-07 三菱瓦斯化学株式会社 Agent réduisant la graisse corporelle
WO2021200216A1 (fr) 2020-04-03 2021-10-07 三菱瓦斯化学株式会社 Agent de renforcement musculaire
JPWO2021200216A1 (fr) * 2020-04-03 2021-10-07
JPWO2021200214A1 (fr) * 2020-04-03 2021-10-07
CN114786502A (zh) * 2020-04-03 2022-07-22 三菱瓦斯化学株式会社 肌肉增强剂
CN114980752A (zh) * 2020-04-03 2022-08-30 三菱瓦斯化学株式会社 体脂减少剂
JP7742026B2 (ja) 2020-04-03 2025-09-19 三菱瓦斯化学株式会社 筋肉増強剤

Also Published As

Publication number Publication date
JP6663598B2 (ja) 2020-03-13
JPWO2018168525A1 (ja) 2019-11-07
KR20190120779A (ko) 2019-10-24
KR102127479B1 (ko) 2020-06-29

Similar Documents

Publication Publication Date Title
TW414807B (en) Maltose-trehalose converting enzyme, and preparation and uses thereof
Hugenholtz et al. Nutraceutical production by propionibacteria
DK2258831T3 (en) GERMMUTANT AND Yeast extract
JP6523579B2 (ja) 乳酸菌の菌体外多糖及びその用途
WO2020177390A1 (fr) Méthode de préparation de solution mère cosmétique contenant de la l-ergothionéine au moyen de la fermentation d&#39;hericium erinaceus
JP5467433B2 (ja) 海藻発酵組成物およびその製造方法
WO2014147280A1 (fr) Microorganisme pouvant convertir l&#39;acide ellagique et les ellagitanins en urolithines et utilisation dudit micro-organisme
JP6679202B2 (ja) Ｉｖ型アレルギー用組成物
CN106460029A (zh) 抑制嘌呤吸收的乳酸菌及其用途
CN102216442A (zh) 富含谷氨酸的酵母的生产方法
JP4313615B2 (ja) 免疫賦活活性及びγ−アミノ酪酸産生能を有する新規乳酸菌、及びその利用。
JPWO2011118807A1 (ja) 酵母の培養方法
JP6663598B2 (ja) ポリアミン高含有酵母及びそれを含む飲食品組成物
Khedr et al. FolE gene expression for folic acid productivity from optimized and characterized probiotic Lactobacillus delbrueckii
JP2009060807A (ja) 新規クロレラ及びその製造方法並びにそのクロレラを含有する健康食品
JP5011543B2 (ja) Ｇａｂａ含有発酵物の製造方法
TW200804591A (en) Lactic acid bacterium having immunoregulatory activity derived from moromi for wine fermentation
JP7464940B2 (ja) γ－アミノ酪酸とシクロアリインを富化したタマネギ及びその製造方法
CA3085995C (fr) Composition pour l&#39;allergie de type i
JP2018023326A (ja) 発酵物
JP4647933B2 (ja) 整腸作用を有する組成物
TW202128980A (zh) Ace阻礙用或血壓上升抑制用之組成物、其製造方法、酵素劑、多核苷酸、及形質轉換體
JP4803971B2 (ja) 脂質代謝改善組成物
JP6370058B2 (ja) ルブソシドの製造方法
JPWO2012067106A1 (ja) 酵母エキスの製造方法

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18768496

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2019505879

Country of ref document: JP

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 20197027111

Country of ref document: KR

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18768496

Country of ref document: EP

Kind code of ref document: A1